Eric Lefkofsky, Co-Founder of Tempus Technologies leads the way for cancer research

Extending beyond the world of science and medicine, the fight for cancer relies on data and information that changes the way we use the internet to transform the health care system. This information is the key to personalizing cancer treatment and patient care because it all starts on a molecular level, which is why the collection of this data is crucial.

Tempus, a Chicago based company is leading the research industry with the development of the world’s largest library of molecular and clinical data. It’s also serves as an operating system that makes this data useful. By collecting massive amounts of data through connections with hospitals and academic institutions, Eric lefkofsky and his team created a two-fold system that allows doctors access to clinical trials that help them determine the most effective treatments for their patients. To know more about him click here.

Lefkofsky saw the treatment first hand when someone close to him was diagnosed with cancer. This process left him feeling dismayed by how little modern technology was used in the treatment process. He learned that cancer research wasn’t as easily understood as it should, even though this data has been constantly collected. Tempus Technologies bridges this gap and helps doctors make more informed decisions based on the data presented to them.

Eric Lefkosky, a Philanthropist and his wife founded the Lefkofsky Family Foundation in 2006, and both serve as a member of the Giving Pledge donating part of their earnings to charities. Lefkofsky co-founded Tempus Technologies and says that “Tempus is unique as it is an end to end solution.”

Lefkofsky serves on the Board of Trustees of the Lurie’s Children Hospital in Chicago, as well as the Art Institute of Chicago and the Museum of Science and Industry. He is the Chairman of the Board of Trustees of the Steppenwolf Theatre Company based in Chicago.